查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1195994

血流测量设备市场——增长、趋势、COVID-19 影响和预测 (2023-2028)

Blood Flow Measurement Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内（2023 年至 2028 年），血流测量设备市场预计将以 9.2% 的复合年增长率增长。

COVID-19 大流行给医疗保健系统带来了巨大挑战。 在 COVID-19 大流行期间，大多数慢性病护理被认为是非紧急护理，因此所有门诊护理都被推迟或限制，以降低病毒传播的风险。 用于家庭监测 COVID-19 患者脉搏血氧饱和度、呼气流量和体温的应急系统。” 2021 年 3 月在 PLOS One 期刊上发表的“开发和初步应用”描述了用于监测 COVID-19 患者的应急系统的开发和评估，该系统也可用于医院。 预计 COVID-19 大流行期间的此类发展将在预测期内推动血流测量设备市场的增长。

包括心血管疾病在内的主要慢性病在全球范围内呈上升趋势，这推动了血流测量设备市场的增长。 随着风险的增加，也有有效的诊断方法可以对患者进行治疗和监测。 心血管疾病患病率的增加在医疗保健中发挥着重要作用。 此外，由于心脏病的增加，越来越多的因素正在增加血流测量设备的市场份额。 例如，根据 2021 年 12 月发表的“印度老年人中的心血管疾病 (CVD) 及其相关风险因素”研究，标题为“印度老年人中的心血管疾病 (CVD) 及其相关风险因素”。 来自 LASI Wave 1 的证据”，在印度 45 岁及以上的人群中，自我报告的诊断为 CVD 的总体患病率为 29.4%。 同样的数据还发现，年龄与较高的 CVD 风险相关，老年女性的 CVD 患病率高于老年男性。 因此，心血管疾病的高负担有望在所研究的市场中发挥主要作用。

一些专注于创新血流测量设备的研发研究也在推动血流测量市场的增长。 例如，2020 年 9 月，印度政府科技部的一篇文章介绍了 Sree ChitraTirunal 医学科学与技术研究所的一个研究团队开发的一种新的具有成本效益的血流计设备。 研究人员发现，这款手掌大小的设备使用新颖的磁方法和信号调节技术测量血流量，符合国家和国际标准和指南，并且来自成熟的国内供应链。表明该产品是使用 这种在血流测量设备设计和製造方面的新颖研究有望在预测期内推动市场的增长。 然而，血流测量的高成本和有限的报销方案预计将阻碍预测期内的市场增长。

血流测量设备的市场趋势

在血流测量设备市场，超声多普勒部分有望占据主要市场份额。

超声多普勒是血流测量设备市场的一个主要部分。 BJA Education 2020 年 4 月发表的题为“Essential notes on the physics of Doppler ultrasound”的论文描述了低能量、非电离波形的超声波在医学成像、治疗和血流速度测量中的应用。它有有人指出，使用超声波能量吸收会导致轻微的局部组织加热，并且超声波暴露被认为比其他诊断成像设备危险性更小。 超声多普勒相对于其他血流测量设备的巨大优势预计将在预测期内推动该细分市场的增长。

2020 年 12 月在 Ultrasonography 上发表的另一篇题为“Doppler sonography in aesthetic medicine”的文章描述了多普勒超声在皮肤和美容药物血流测量中的好处。 . 这篇文章表明，成像皮肤血管目前很少见，但在美容领域是一种非常有用的方法。 在预测期内，多普勒超声在各个医疗领域的使用越来越多，预计将刺激血流测量设备市场这一细分市场的增长。

此外，在2020年5月发表于英国放射学杂誌的文章《多普勒超声、CT和MRI对布加综合征的诊断准确性：系统评价和荟萃分析》中，布加综合征（BCS）的诊断对多普勒超声、CT 和 MRI 的敏感性、特异性和诊断优势比 (DOR) 进行了评估。 该论文表明，对于疑似 BCS 患者，多普勒是一种优越的一线影像学检查。 多普勒超声的优势在于其可用性和低成本。 多普勒超声还提供有关狭窄的功能信息。 这些优势正在推动研究期间的市场增长。

此外，市场上推出新型血流测量设备将在预测期内刺激该细分市场的增长。 例如，2021年8月，Trivitron推出了SonoRad V60 Ultrasound，致力于提供卓越的成像系统和出色的图像质量。 该设备采用创新的 Colorflow 技术，可改善血流的可视化。 预计此类产品的推出将推动预测期内所研究市场的增长。

预计在预测期内北美将占据很大的市场份额

在血流测量设备製造中越来越多地采用先进技术和系统，以及血流研究领域的技术进步预计将推动北美地区的市场增长。 人们对市场上创新血流测量设备的可用性的高度认识有助于该地区的高市场增长。

北美地区慢性病患者患病率上升正在刺激血流测量设备市场的增长。 例如，根据 GLOBOCAN 2020 报告，2020 年北美地区报告了约 260 万例癌症病例，预计到 2040 年将增加到 350 万例。 同样，根据美国疾病控制和预防中心 (CDC) 2022 年 7 月更新，美国每年记录大约 805,000 例心脏病发作病例，其中 605,000 例是首次心脏病发作患者。其余 200,000 例已经以前有过心脏病发作。 根据同一数据，五分之一的心脏病发作是“无声的发作”，这意味着一个人心脏病发作但没有意识到。 因此，慢性病的高负担将推动该地区对包括血流测量在内的诊断的需求，这有望在预测期内推动市场增长。

2021 年 1 月，Nuralogix 发布了 Anura，这是一款无需袖带或其他可穿戴设备即可进行非接触式血压测量的应用程序。 Anura 以医疗级精度测量身体、生理和心理指标，例如心率、压力水平、BMI 和心血管疾病风险。 此类创新设备的推出有望推动市场增长。 因此，众所周知，对血流测量设备的需求不断增长，加上医疗领域投资的增加，将推动该地区的市场增长。

血流测量设备市场竞争者分析

血流测量设备市场竞争激烈，由几家主要参与者组成。 从市场份额的角度来看，一些主要参与者目前主导着市场。 目前主导市场的公司包括 Cook Group Incorporated、Medistim ASA、Compumedics、Deltex Medical Group、Perimed AB、ADInstruments、Atys Medical、Moor Instruments Ltd.、SONOTEC GmbH、Transonic 等。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动力
    • 心血管疾病患病率上升和老年人口增加
    • 产品技术进步
  • 市场製约因素
    • 血流测量设备成本高
    • 有限的赎回方案
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于金额，单位：百万美元）

  • 按产品分类
    • 超声诊断设备
      • 超声多普勒
      • 时差流量计
    • 激光多普勒
  • 通过申请
    • 血管内治疗
      • 微血管手术
      • 冠状动脉搭桥手术
      • 其他
    • 非侵入性
      • 心血管疾病
      • 胃肠病学
      • 肿瘤监测
      • 其他
  • 最终用户
    • 医院
    • 门诊手术中心
    • 其他
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • Cook Group Incorporated
    • Medistim ASA
    • Compumedics
    • Deltex Medical Group
    • Perimed AB
    • ADInstruments
    • Atys Medical
    • Moor Instruments Ltd.
    • SONOTEC GmbH
    • Transonic
    • Carolina Medical Inc.
    • ArjoHuntleigh, Inc.

第7章 市场机会与今后动向

简介目录
Product Code: 68127

The blood flow measurement devices market is projected to register a CAGR of 9.2% during the forecast period (2023 - 2028).

The healthcare system has witnessed enormous challenges because of the COVID-19 pandemic. All outpatient treatments were postponed or restricted during the COVID-19 pandemic to reduce the risk of viral transmission as most chronic therapies were regarded as non-urgent. An article titled "An emergency system for monitoring pulse oximetry, peak expiratory flow, and body temperature of patients with COVID-19 at home: Development and preliminary application" published in the journal PLOS One in March 2021 discussed the development and evaluation of an emergency system for monitoring patients with COVID-19, which may be useful in hospitals. Such developments in the time of the COVID-19 pandemic are expected to propel the growth of the blood flow measurement devices market in the forecast period.

Major chronic diseases including cardiovascular diseases are on the rise all over the world, which is adding to the growth of the blood flow measurement devices market. With increasing risks, there are also effective diagnostics that lead to the treatment and monitoring of patients. The rise in the number of cardiovascular disease cases plays an important role in healthcare. In addition, the growing number of factors attributing to the rise in cardiac diseases is increasing the market share for the blood flow measurement devices segment. For instance, according to the research study published in December 2021, titled "Cardiovascular disease (CVD) and its associated risk factors among older adults in India: Evidence from LASI Wave 1", for older persons in India who were 45 years of age and above, the overall self-reported prevalence of diagnosed CVDs was 29.4%. also, as per the same source, age was linked to a higher risk of CVD and female older individuals had a higher CVD prevalence than male older adults. Hence, the high burden of cardiovascular diseases is expected to play a major role in the studied market.

Several research and development studies focusing on innovative blood flow measurement devices are also adding to the growth of the blood flow device measurement market. For instance, in September 2020, the Government of India Ministry of Science & Technology's article discussed a new cost-effective blood flow meter device by a team of researchers at the Sree ChitraTirunal Institute for Medical Sciences and Technology. The researchers indicated that the palm-sized device measures the flow rate of blood using a novel magnetic method and a signal conditioning technique and is compliant with national and international standards and guidelines and is manufactured using components sourced from established supply chains within the country. Such novel research in the design and manufacturing of blood flow measurement devices is expected to boost the growth of the studied market in the forecast period. However, the high cost of the blood flow measurement and limited reimbursement scenario are expected to hamper the market growth over the forecast period.

Blood Flow Measurement Devices Market Trends

Ultrasound Dopplers Segment is Expected to Hold a Major Market Share in the Blood Flow Measurement Devices Market.

Ultrasound dopplers hold the major segment in the blood flow measurement devices market. An article titled "Essential notes on the physics of Doppler ultrasound" presented in the journal of BJA Education in April 2020 indicated that the use of low energy, non-ionizing waveform ultrasound in medicine for imaging, therapy, and measurement of blood velocity means that ultrasound exposures are thought to be less hazardous than other imaging modalities, though mild local tissue heating occurs with the absorption of ultrasound energy. The huge advantages of ultrasound dopplers over other blood flow measurement devices are expected to propel the growth of the segment in the forecast period.

Another article published in the journal of Ultrasonography in December 2020 titled "Usefulness of Doppler sonography in aesthetic medicine" discussed the advantages of ultrasound dopplers in blood flow measurement for dermal and aesthetic medicines. The article indicated that though the imaging of skin vessels is currently rare, the method is very useful in the aesthetics division. The rise in the use of ultrasound dopplers in various medical sectors is expected to add to the growth of the segment in the blood flow measurement devices market in the forecast period.

Also, an article titled "Diagnostic accuracy of Doppler ultrasound, CT and MRI in Budd Chiari syndrome: systematic review and meta-analysis" presented in the British Journal of Radiology in May 2020 evaluated the sensitivity, specificity, and diagnostic odds ratio (DOR) of Doppler ultrasound, CT, and MRI in the diagnosis of Budd Chiari syndrome (BCS). The article suggested that Doppler is an excellent first-line imaging test for patients suspected to have BCS. The advantages of Doppler ultrasound are easy availability and lower cost. Doppler ultrasound also provides functional information regarding stenosis. Such advantages are driving the growth of the market in the study period.

Also, the launch of novel blood flow measurement devices in the market is adding to the segment's growth over the forecast period. For instance, in August 2021, Trivitron launched SonoRad V60 Ultrasound devoted to delivering excellent imaging systems and exceptional image quality. The device is equipped with innovative color flow technology that improves blood flow visualization. Such product launches are expected to boost the growth of the studied market during the forecast period.

North America is Expected to Hold a Significant Share in the Market Over Forecast Period

The rise in the adoption of highly advanced techniques and systems in the manufacturing of blood flow measurement devices and the technological advancements made in blood flow studies is expected to boost the growth of the market in the North American region. The high awareness among the population on the availability of innovative blood flow measurement devices in the market contributes to the high market growth in the region.

The rising prevalence of chronic disease cases in the North American region is adding to the growth of the blood flow measurement devices market. For instance, according to the GLOBOCAN 2020 report, about 2.6 million cases of cancer were reported in Northern America region in 2020, which is further projected to increase to 3.5 million cases by 2040. Similarly, according to the July 2022 update of the Centers for Disease Control and Prevention (CDC), approximately 805,000 heart attack incidences are recorded every year in the United States, of which 605,000 people had a heart attack the first time and the remaining 200,000 were those who already had a heart attack before. Further as per the same source, about 1 in 5 heart attacks are silent which means the person had a heart attack but was not aware of it. Hence, the high burden of chronic diseases is expected to increase the requirement of diagnosis including blood flow measurement in the region which is expected to boost market growth over the forecast period.

In January 2021, Nuralogix launched their app Anura, allowing for contactless blood pressure measurement, without the need for cuffs or other wearables. Anura measures physical, physiological, and psychological indexes, including heart rate, stress levels, BMI, and cardiovascular disease risks with medical grade accuracy. The launch of such innovative devices is expected to boost the growth of the market. Thus, the increasing necessity for blood flow measurement devices coupled with increasing investment in the health care department is known to propel the growth of the market in this region.

Blood Flow Measurement Devices Market Competitor Analysis

The blood flow measurement devices market is fairly competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market areCook Group Incorporated, Medistim ASA, Compumedics, Deltex Medical Group, Perimed AB, ADInstruments, Atys Medical, Moor Instruments Ltd., SONOTEC GmbH, Transonic and others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Cardiovascular Diseases and Growing Geriatric Population
    • 4.2.2 Advancements in Product Technologies
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Blood Flow Measurement Devices
    • 4.3.2 Limited Reimbursement Scenario
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - in USD Millions)

  • 5.1 By Product
    • 5.1.1 Ultrasound Devices
      • 5.1.1.1 Ultrasound Doppler
      • 5.1.1.2 Transit-Time Flow Meters
    • 5.1.2 Laser Doppler
  • 5.2 By Application
    • 5.2.1 Invasive
      • 5.2.1.1 Microvascular Surgery
      • 5.2.1.2 Coronary Artery Bypass Surgery
      • 5.2.1.3 Others
    • 5.2.2 Non-Invasive
      • 5.2.2.1 Cardiovascular Disease
      • 5.2.2.2 Gastroenterology
      • 5.2.2.3 Tumor Monitoring
      • 5.2.2.4 Others
  • 5.3 By End-User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Cook Group Incorporated
    • 6.1.2 Medistim ASA
    • 6.1.3 Compumedics
    • 6.1.4 Deltex Medical Group
    • 6.1.5 Perimed AB
    • 6.1.6 ADInstruments
    • 6.1.7 Atys Medical
    • 6.1.8 Moor Instruments Ltd.
    • 6.1.9 SONOTEC GmbH
    • 6.1.10 Transonic
    • 6.1.11 Carolina Medical Inc.
    • 6.1.12 ArjoHuntleigh, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS